Drug Industry Concept

Vocabulary Service

MeSH

Overview

subject area of

ASH Guideline Oversight Subcommittee Response to Jacobs et al regarding Industry Payments to ASH Guideline Panelists Journal Articles
Academic medicine and the pharmaceutical industry: a cautionary tale. Journal Articles
Agreements between industry and academia on publication rights: A retrospective study of protocols and publications of randomized clinical trials Journal Articles
Antileukotrienes, asthma pathogenesis and the pharmaceutical industry. Journal Articles
Assessing the quality of drug detailing Journal Articles
Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. Journal Articles
Association between physicians’ interaction with pharmaceutical companies and their clinical practices: A systematic review and meta-analysis Journal Articles
Awareness and attitudes of the Lebanese population with regard to physician–pharmaceutical company interaction: a survey study Journal Articles
BEACON: A Summary Framework to Overcome Potential Reimbursement Hurdles Journal Articles
Balancing quality and cost: a public decision-making process. Journal Articles
Bill C-91: the debate continues. Journal Articles
Canada’s New Generic Pricing Policy: A Reasoned Approach to a Challenging Problem Journal Articles
Canada’s laws on pharmaceutical intellectual property: the case for fundamental reform: Figure 1: Journal Articles
Clinical experts or methodologists to write clinical guidelines? Journal Articles
Combination Therapy to Prevent Cardiovascular Disease Journal Articles
DRUG DISINVESTMENT FRAMEWORKS: COMPONENTS, CHALLENGES, AND SOLUTIONS Journal Articles
DTCA in New Zealand: the challenge of finding an acceptable balance. Journal Articles
Determining an ethical stance. Pharmaceutical industry involvement and family medicine residency training. Journal Articles
Determining optimal sample sizes for multistage adaptive randomized clinical trials from an industry perspective using value of information methods Journal Articles
Determining the price for pharmaceuticals in Germany: comparing a shortcut for IQWiG's efficiency frontier method with the price set by the manufacturer for ticagrelor Journal Articles
Development of a standardized, comprehensive "ideal drug detail". Journal Articles
Development of residency program guidelines for interaction with the pharmaceutical industry. Education Council, Residency Training Programme in Internal Medicine, Department of Medicine, McMaster University, Hamilton, Ont. Journal Articles
Direct to consumer advertising Journal Articles
Direct-to-consumer advertisements for HIV antiretroviral medications: a progress report. Journal Articles
Disappearing Acts: Anguish, Isolation, and the Re-imagining of the Mentally Ill in Global Psychopharmaceutical Advertising (1953–2005) Journal Articles
Do editors live up to the Sept 10, 2001, expectations? Journal Articles
Doctors must be trained to assess credibility Journal Articles
Does the Imprecise Definition of Overactive Bladder Serve Commercial Rather than Patient Interests? Journal Articles
Extent of physician–pharmaceutical industry interactions in low-and middle-income countries: a systematic review Journal Articles
Factors associated with drug shortages in Canada: a retrospective cohort study Journal Articles
Fair, just and compassionate: A pilot for making allocation decisions for patients requesting experimental drugs outside of clinical trials Journal Articles
Financial Concerns Prompt Sponsoring Pharmaceutical Company to Halt International Phase I Studies Journal Articles
Financial relationships between patient and consumer representatives and the health industry: A systematic review Journal Articles
Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery Journal Articles
GRADE guidelines: 5. Rating the quality of evidence—publication bias Journal Articles
Healing an ailing pharmaceutical system: prescription for reform for United States and Canada Journal Articles
Health sciences and the pharmaceutical industry: partnerships can be effective and ethical. Journal Articles
How should we support pharmaceutical innovation? Journal Articles
Improving Cancer Outcomes Through International Collaboration in Academic Cancer Treatment Trials Journal Articles
Improving academic leadership and oversight in large industry-sponsored clinical trials: the ARO-CRO model Journal Articles
Industry Funding by Itself is Not a Reason for Rating Down Studies for Risk of Bias. Journal Articles
Industry funded patient information and the slippery slope to New Zealand Journal Articles
Integrating medication samples into the traditional community pharmacy supply chain: a feasibility study Journal Articles
Interactions with the pharmaceutical industry: a survey of family medicine residents in Ontario. - PubMed - NCBI Other
Investigator-initiated trials are more impartial Journal Articles
Is the GAIN Act a turning point in new antibiotic discovery? Journal Articles
Knowledge, beliefs and attitudes of patients and the general public towards the interactions of physicians with the pharmaceutical and the device industry: a systematic review Journal Articles
Knowledge, beliefs and attitudes of physicians in low and middle-income countries regarding interacting with pharmaceutical companies: a systematic review Journal Articles
LETTERS TO THE EDITOR Journal Articles
Legislative, educational, policy and other interventions targeting physicians’ interaction with pharmaceutical companies: a systematic review Journal Articles
Lessons from assembling a microbial natural product and pre-fractionated extract library in an academic laboratory Journal Articles
Let's have "ozone-friendly" pharmaceutical products. Journal Articles
Managing drug shortages during a pandemic: tocilizumab and COVID-19 Journal Articles
Methodologic quality and relevance of references in pharmaceutical advertisements in a Canadian medical journal. Journal Articles
New Zealand deserves better. Direct-to-consumer advertising (DTCA) of prescription medicines in New Zealand: for health or for profit? Journal Articles
New approaches to rewarding pharmaceutical innovation Journal Articles
New drug development Journal Articles
No free lunch. Journal Articles
Novel approaches to discovery of antibacterial agents Journal Articles
Optimal Global Value of Information Trials: Better Aligning Manufacturer and Decision Maker Interests and Enabling Feasible Risk Sharing Journal Articles
Optimal sample size determinations from an industry perspective based on the expected value of information Journal Articles
Oral anticoagulant therapy. Urgent need for standardization. Journal Articles
Pediatric drug data in Canadian drug monographs: a descriptive analysis Journal Articles
Physicians' negative views of direct-to-consumer advertising (DTCA): the international evidence grows. Journal Articles
Promoting cost effective prescribing Journal Articles
Response to Maubach and Hoek's paper on GP attitudes to DTCA. Journal Articles
Revitalizing Pharmaceutical Innovation For Global Health Journal Articles
SSRI treatment for under-18s Journal Articles
Something old, something new: revisiting natural products in antibiotic drug discovery Journal Articles
Stakeholder Involvement: How to Do It Right Journal Articles
Stakeholders’ feedback on the proposed recommendations for updating the patented medicine prices review board (pmprb) budget impact analysis guidelines Journal Articles
Stopping a trial early in oncology: for patients or for industry? Journal Articles
Summary of the executive session on critical threats to the pharmacy supply chain and the effects on patient care. Journal Articles
The Impact of Drug Vintage on Patient Survival: A Patient-Level Analysis Using Quebec's Provincial Health Plan Data Journal Articles
The Impact of Tiered-Pricing Framework on Generic Entry in Canada Journal Articles
The Inflation Reduction Act: An Opportunity to Accelerate Confidence in Real-World Evidence in the United States Journal Articles
The NICE Reference Case Requirement Journal Articles
The Opportunity Cost of Capital Journal Articles
The Process Analytical Technology initiative and multivariate process analysis, monitoring and control Journal Articles
The Self-Perceived Role and Educational Needs of Pharmaceutical Representatives: A Survey Journal Articles
The art and science of marketing medications. Journal Articles
The cost of drug development: A systematic review Journal Articles
The leadership role of general practice in public health: advocating a ban of direct-to-consumer advertising of prescription drugs in New Zealand. 'Possums in the headlights?'. Journal Articles
The shipwreck of the singular Journal Articles
Transforming an Academic Radiochemistry Facility for Positron Emission Tomography Drug cGMP Compliance Journal Articles
Unwarranted claims of drug efficacy in pharmaceutical sales visits: are drugs approved on the basis of surrogate outcomes promoted appropriately? Journal Articles
Validity of tools used for surveying physicians about their interactions with pharmaceutical company: a systematic review Journal Articles
Value of Information and Pricing New Healthcare Interventions Journal Articles
Value-based arrangements may be more prevalent than assumed Journal Articles
What do Canadians think about physician–pharmaceutical industry interactions? Journal Articles
When are Pharmaceuticals Priced Fairly? An Alternative Risk-Sharing Model for Pharmaceutical Pricing Journal Articles
Why West Africa rejected donation of Chinese medicine for treating Ebola recommended by Chinese government? Journal Articles
“A magical little pill that will relieve you of your womanly issues”: What young women say about menstrual suppression Journal Articles